scholarly journals Invasive fungal infection in immunocompetent trauma patients – A case series

2018 ◽  
Vol 9 ◽  
pp. S10-S14 ◽  
Author(s):  
Senthil Loganathan ◽  
Gowtham.A.E Ajay ◽  
U. Thyagarajan ◽  
Raj.D Gokul
Keyword(s):  
Fungal Infection ◽  
Invasive Fungal Infection ◽  
Case Series ◽  
Trauma Patients

scholarly journals Invasive fungal infection by Aspergillus flavus in immunocompetent hosts: A case series and literature review

2019 ◽  
Vol 23 ◽  
pp. 12-15 ◽  
Author(s):  
Ana María Garcia-Giraldo ◽  
Barbara Lucia Mora ◽  
Jorge Mario Loaiza-Castaño ◽  
Jorge Andrés Cedano ◽  
Fernando Rosso
Keyword(s):  
Literature Review ◽  
Fungal Infection ◽  
Aspergillus Flavus ◽  
Invasive Fungal Infection ◽  
Case Series

scholarly journals Fosfluconazole for Antifungal Prophylaxis in Very Low Birth Weight Infants

2009 ◽  
Vol 2009 ◽  
pp. 1-3
Author(s):  
Daijiro Takahashi ◽  
Tomohiko Nakamura ◽  
Reiko Shigematsu ◽  
Miyu Matsui ◽  
Shunsuke Araki ◽  
...  
Keyword(s):  
Central Venous Catheter ◽  
Fungal Infection ◽  
Invasive Fungal Infection ◽  
Very Low Birth Weight ◽  
Case Series ◽  
Venous Catheter ◽  
Antifungal Prophylaxis ◽  
Central Venous ◽  
Vlbw Infants ◽  
Case Series Study

We conducted a retrospective case series study to evaluate the safety of fosfluconazole prophylaxis for preventing invasive fungal infection in VLBW infants with a central vascular access. Fosfluconazole was administered intravenously at a dose of 6 mg/kg everyday during which time a central venous catheter was placed. A total of 23 infants met the criteria for enrollment in our study. No cases of fungal infection were detected during the central venous catheter placement in the group. None of the infants had an elevatedβ-D-glucan, and all of them were still alive at discharge. Regarding the liver and renal function, no statistically significant differences were observed before and at the end of fosfluconazole prophylaxis. The results of this study demonstrate that fosfluconazole prophylaxis in preventing invasive fungal infection was well tolerated by VLBW infants. This is a first report to describe antifungal prophylaxis using fosfluconazole for VLBW infants.

Sign in / Sign up

Export Citation Format

Share Document